The Biomembrane Institute

Patent Applications and Registrations

Patent applications and USPTO patent grants for The Biomembrane Institute.The latest application filed is for "extended type 1 chain glycosphingolipids as tumor-associated antigens".

Company Profile

0.15.0

The Biomembrane Institute - Seattle WA
The Biomembrane Institute - WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Extended type 1 chain glycosphingolipids as tumor-associated antigens Grant 6,294,523 - Levery , et al. September 25, 2	2001-09-25
Carbohydrate ligands (myelorollin) that cause E-selectin dependent cell rolling and adhesion under dynamic flow system Grant 6,133,239 - Handa , et al. October 17, 2	2000-10-17
Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates Grant 5,747,048 - Kjeldsen , et al. May 5, 1	1998-05-05
Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates Grant 5,660,834 - Kjeldsen , et al. August 26, 1	1997-08-26
Compounds and methods for monosaccharide analysis Grant 5,585,473 - Bendiak December 17, 1	1996-12-17
Methylsphingosine used to treat apoptosis Grant 5,583,160 - Igarashi , et al. December 10, 1	1996-12-10
Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives Grant 5,391,800 - Igarashi , et al. February 21, 1	1995-02-21
ABO genotyping Grant 5,326,857 - Yamamoto , et al. July 5, 1	1994-07-05
Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by O-glycosylation modification Grant 5,268,364 - Kojima , et al. December 7, 1	1993-12-07
Method for inhibition of cell motility by sphingosine-1-phosphate and derivatives Grant 5,260,288 - Igarashi , et al. November 9, 1	1993-11-09
Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides Grant 5,240,833 - Nudelman , et al. August 31, 1	1993-08-31
Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates Grant 5,229,289 - Kjeldsen , et al. July 20, 1	1993-07-20
Trifluoromethyl analogs of fucose and uses thereof Grant 5,210,078 - Toyokuni , et al. May 11, 1	1993-05-11
Effect of N,N,N-trimethylsphingosine on protein kinase-C activity, melanoma cell growth in vitro, metastatic potential in vivo and human platelet aggregation Grant 5,151,360 - Handa , et al. September 29, 1	1992-09-29
Effect of N,N,N,-trimethylsphingosine on protein kinase C activity melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation Grant 5,137,919 - Igarashi , et al. August 11, 1	1992-08-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.